← Open Payments lookup

DAVID RICHARDSON: Open Payments

NPI 1356570188 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,921 in 114 payments from 22 companies in 2025. Trend: 2023 $1,816 · 2024 $2,121 · 2025 $1,921

Food & beverage: $1,921
CompanyPaymentsAmount
ABBVIE INC.25$305
Novo Nordisk Inc15$278
AstraZeneca Pharmaceuticals LP9$188
GlaxoSmithKline, LLC.9$163
Lilly USA, LLC7$128
PFIZER INC.6$121
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$77
Boehringer Ingelheim Pharmaceuticals, Inc.3$70
Phathom Pharmaceuticals, Inc.9$66

Products named: TRELEGY ELLIPTA, QULIPTA, JARDIANCE, Wegovy, UBRELVY, CAPLYTA, FARXIGA, VRAYLAR.

Industry payments across NC — which companies pay providers there.